polybrene drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (15)
Papers in which this entity is mentioned.
- Single-cell exon deletion profiling reveals splicing events that shape gene expression and cell state dynamics. (2026)
- Multigenerational cell tracking of DNA replication and heritable DNA damage. (2025)
- Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
- Tracing the evolution of single-cell 3D genomes in Kras-driven cancers. (2025)
- MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. (2025)
- Massively parallel reporter perturbation assays uncover temporal regulatory architecture during neural differentiation. (2022)
- Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers. (2020)
- Genome-Informed Targeted Therapy for Osteosarcoma. (2019)
- Mutational processes shape the landscape of TP53 mutations in human cancer. (2018)
- Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. (2018)
- EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma. (2018)
- Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain. (2017)
- A germline polymorphism of thymine DNA glycosylase induces genomic instability and cellular transformation. (2014)
- Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. (2014)
- Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. (2014)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| polybrene | drug | 21 | 30 |